Beyond Cancer™ Selected to Present Proffered Posters Discussing Data from the UNO Therapy Program at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

GARDEN CITY, N.Y. and HAMILTON, Bermuda, Oct. 04, 2023 -- Beyond Cancer, Ltd., an affiliate of Beyond Air, Inc. that is developing ultra-high concentration nitric oxide as an immunotherapeutic...

Related Keywords

Jerusalem ,Israel General ,Israel ,Boston ,Massachusetts ,United States ,Bermuda ,American ,Fred Dirbas ,Matt Johnson ,Sunil Panchal ,Mark Pegram ,Yana Epshtein ,Corey Davis ,International Conference On Molecular ,Details Of The Company ,Lifesci Advisors ,Clinical Translational Research Unit ,Intratumoral Administration Of Ultra High ,Stanford University ,National Cancer Institute ,European Organisation For Research ,American Association For Cancer Research ,Nasdaq ,Globenewswire Inc ,Exchange Commission ,National Institute Of Spine ,Stanford University School Of Medicine ,Dean For Clinical Research Quality ,Cancer Ltd ,Corporate Development Strategy ,Hebrew University Of Jerusalem ,International Conference ,Molecular Targets ,Cancer Therapeutics ,Ultra High Concentration Nitric Oxide ,High Tumor Regression Rates ,Prolonged Survival ,Poster Session ,Exhibit Hall ,Translational Science ,Vitro Studies ,Advisory Board ,Surgical Oncology ,University School ,Yuan Huey Hung Professor ,Medical Director ,Associate Dean ,Clinical Research Quality ,Nitric Oxide ,Autism Spectrum ,Beyond Cancer ,Beyond Air ,Annual Report ,Sci Advisors ,Markets ,